ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Summit Corporation gets green light for human trials of Duchenne Muscular Dystro

Share Forum

Share On Facebook
Creator lucky_punter Created 24 Apr 2012 Posts 3 Last Post 10 years ago
Free Annual Reports Add Favourite|E-mail Alert|Related Threads
The drug discovery group Summit Corporation (LON:SUM) has received the green light for human trials of its potentially breakthrough treatment for Duchenne Muscular Dystrophy.

http://www.proactiveinvestors.co.uk/companies/news/41861/summit-corporation-gets-green-light-for-human-trials-of-duchenne-muscular-dystrophy-drug-41861.html